Changes in plasma lipids with psychosocial stress are related to hypertension status and the norepinephrine stress response

Metabolism: Clinical and Experimental

Volumn 58, Issue 1, 2009, Pages 30-37

  Wirtz, Petra H ^a   Ehlert, Ulrike ^a   Bärtschi, Carmen ^a   Redwine, Laura S ^b   von Känel, Roland ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORADRENALIN; TRIACYLGLYCEROL;

ADULT; ARITHMETIC; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOCONCENTRATION; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; MENTAL STRESS; PRIORITY JOURNAL; PUBLIC SPEAKING;

ADULT; AGED; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; HEART RATE; HEMATOCRIT; HEMOGLOBINS; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; NOREPINEPHRINE; REGRESSION ANALYSIS; STRESS, PSYCHOLOGICAL; TRIGLYCERIDES; YOUNG ADULT;

EID: 57049133540     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.08.003     Document Type: Article

References (50)

1. Kaplan N.M. Importance of coronary heart disease risk factors in the management of hypertension. An overview. Am J Med 86 (1989) 1-4
2. Palatini P., Longo D., Zaetta V., Perkovic D., Garbelotto R., and Pessina A.C. Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity. J Hypertens 24 (2006) 1375-1381
3. Julius S., and Nesbitt S. Sympathetic overactivity in hypertension. A moving target. Am J Hypertens 9 (1996) 113S-120S
4. Everson S.A., Lynch J.W., Kaplan G.A., Lakka T.A., Sivenius J., and Salonen J.T. Stress-induced blood pressure reactivity and incident stroke in middle-aged men. Stroke 32 (2001) 1263-1270
5. Goldstein D.S. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 5 (1983) 86-99
6. Rahn K.H., Barenbrock M., and Hausberg M. The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens Suppl 17 (1999) S11-S14
7. Scheuch K., Hanefeld M., Grässler J., Seibt R., and Naumann H.J. Hypertriglyceridaemia in mild hypertension: impact on cardiovascular and hormonal reactivity under different stress tests. J Hum Hypertens 13 (1999) 533-539
8. Flaa A., Mundal H.H., Eide I., Kjeldsen S., and Rostrup M. Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension 47 (2006) 396-402
9. Wirtz P.H., von Känel R., Mohiyeddini C., Emini L., Ruedisueli K., Groessbauer S., et al. Low social support and poor emotional regulation are associated with increased stress hormone reactivity to mental stress in systemic hypertension. J Clin Endocrinol Metab 91 (2006) 3857-3865
10. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., and Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256 (1986) 2835-2838
11. Bonaa K.H., and Thelle D.S. Association between blood pressure and serum lipids in a population. The Tromsø Study. Circulation 83 (1991) 1305-1314
12. Steptoe A., and Brydon L. Associations between acute lipid stress responses and fasting lipid levels 3 years later. Health Psychol 24 (2005) 601-607
13. Niaura R., Stoney C.M., and Herbert P.N. Lipids in psychological research: the last decade. Biol Psychol 34 (1992) 1-43
14. Muldoon M.F., Herbert T.B., Patterson S.M., Kameneva M., Raible R., and Manuck S.B. Effects of acute psychological stress on serum lipid levels, hemoconcentration, and blood viscosity. Arch Intern Med 155 (1995) 615-620
15. Allen M.T., and Patterson S.M. Hemoconcentration and stress: a review of physiological mechanisms and relevance for cardiovascular disease risk. Biol Psychol 41 (1995) 1-27
16. Patterson S.M., Gottdiener J.S., Hecht G., Vargot S., and Krantz D.S. Effects of acute mental stress on serum lipids: mediating effects of plasma volume. Psychosom Med 55 (1993) 525-532
17. Bachen E.A., Muldoon M.F., Matthews K.A., and Manuck S.B. Effects of hemoconcentration and sympathetic activation on serum lipid responses to brief mental stress. Psychosom Med 64 (2002) 587-594
18. Stoney C.M., Matthews K.A., McDonald R.H., and Johnson C.A. Sex differences in lipid, lipoprotein, cardiovascular, and neuroendocrine responses to acute stress. Psychophysiology 25 (1988) 645-656
19. Stoney C.M., Bausserman L., Niaura R., Marcus B., and Flynn M. Lipid reactivity to stress. II. Biological and behavioral influences. Health Psychol 18 (1999) 251-261
20. Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19 (2005) 471-482
21. Hjemdahl P., and Linde P. Adrenergic control of blood flow and lipolysis in human adipose tissue. In: Refsum H.M. (Ed). Alpha-adrenoreceptor blockers in cardiovascular disease (1985), Churchill Livingstone, London 151-164
22. McCann B.S., Magee M.S., Broyles F.C., Vaughan M., Albers J.J., and Knopp R.H. Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: effects on plasma lipid and apoprotein concentrations. Psychosom Med 57 (1995) 165-176
23. Ligueros M., Unwin R., Wilkins M.R., Humphreys J., Coles S.J., and Cleland J. A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to moderate essential hypertension. Clin Auton Res 2 (1992) 373-381
24. Andersen P., Seljeflot I., Herzog A., Arnesen H., Hjermann I., and Holme I. Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men. J Cardiovasc Pharmacol 31 (1998) 677-683
25. Hobbs F.R., Khan T., and Collins B. Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension. Br J Gen Pract 55 (2005) 437-443
26. Kirschbaum C., Pirke K.M., and Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 (1993) 76-81
27. Buske-Kirschbaum A., Ebrecht M., Kern S., and Hellhammer D.H. Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris)-do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)?. Psychoneuroendocrinology 31 (2006) 439-446
28. Nater U.M., La Marca R., Florin L., Moses A., Langhans W., Koller M.M., et al. Stress induced changes in human salivary alpha-amylase activity-associations with adrenergic activity. Psychoneuroendocrinology 31 (2006) 49-58
29. Kjeldsen S.E., Erdine S., Farsang C., Sleight P., and Mancia G. 1999 WHO/ISH hypertension guidelines-highlights & ESH update. J Hypertens 20 (2002) 153-155
30. Dickerson S.S., and Kemeney M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull 130 (2004) 355-391
31. Nater U.M., Rohleder N., Gaab J., Berger S., Jud A., Kirschbaum C., et al. Human salivary alpha-amylase reactivity in a psychosocial stress paradigm. Int J Psychophysiol 55 (2005) 333-342
32. Dill D.B., and Costill D.L. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37 (1974) 247-248
33. Bacon S.L., Ring C., Lip G.Y., and Carroll D. Increases in lipids and immune cells in response to exercise and mental stress in patients with suspected coronary artery disease: effects of adjustment for shifts in plasma volume. Biol Psychol 65 (2004) 237-250
34. MacCallum R.C., Zhang S., Preacher K.J., and Rucker D. On the practice of dichotomization of quantitative variables. Psychol Methods 7 (2002) 19-40
35. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66 (2004) 411-421
36. Buchner A., Faul F., and Erdfelder E. G-Power: a priori, post-hoc, and compromise power analyses for the Macintosh. 2.1.2 ed (1997), University of Trier, Trier
37. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 316 (1998) 1236-1238
38. Berlan M., Galitzky J., Riviere D., Foureau M., Tran M.A., Flores R., et al. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and nonobese women. Int J Obes 15 (1991) 305-315
39. Wahrborg P. Mental stress and ischaemic heart disease: an underestimated connection. Eur Heart J 19 Suppl O (1998) O20-O23
40. Esch T., Stefano G.B., Fricchione G.L., and Benson H. Stress in cardiovascular diseases. Med Sci Monit 8 (2002) RA93-RA101
41. Strike P.C., and Steptoe A. Behavioral and emotional triggers of acute coronary syndromes: a systematic review and critique. Psychosom Med 67 (2005) 179-186
42. Tavernier G., Jimenez M., Giacobino J.P., Hulo N., Lafontan M., Muzzin P., et al. Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice. Mol Pharmacol 68 (2005) 793-799
43. Biaggioni I. Sympathetic control of the circulation in hypertension: lessons from autonomic disorders. Curr Opin Nephrol Hypertens 12 (2003) 175-180
44. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
45. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J Med 338 (1998) 171-179
46. Gianaros P.J., Bleil M.E., Muldoon M.F., Jennings J.R., Sutton-Tyrrell K., McCaffery J.M., et al. Is cardiovascular reactivity associated with atherosclerosis among hypertensives?. Hypertension 40 (2002) 742-747
47. Ansell B. Future directions in lipid therapies. Adv Ther 19 (2002) 61-72
48. Borghi C., Veronesi M., Bacchelli S., Esposti D.D., Cosentino E., and Ambrosioni E. Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure. J Hypertens 22 (2004) 265-272
49. Jones P.J., and Schoeller D.A. Evidence for diurnal periodicity in human cholesterol synthesis. J Lipid Res 31 (1990) 667-673
50. Miettinen T.A. Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J Lipid Res 23 (1982) 466-473